Sylvain Chrétien - President, Chief Executive Officer and Director
Mr. Chrétien is the founder, President and CEO of Pediapharm since January 2008. He has over 27 years of experience in both the pharmaceutical and the biotechnology sectors, where he occupied various executive positions in sales, marketing and business development. He worked with Nordic Laboratories, Pfizer Canada and Biorthex Inc. Before founding Pediapharm, Mr. Chrétien had his own consulting company called Gestion BioPrisma. Mr. Chrétien was a Director of Biophage Pharma and Warnex. He was President of the Pharmaceutical Marketing Club of Quebec (PMCQ) in 1998 and executive member of BioQuébec in 2000. In 2015, he was inducted into the Canadian Healthcare Marketing Hall of Fame. Mr. Chrétien holds an MBA in Management of Bio Industries from the Université du Québec à Montréal and a B.Sc. in Sciences of Physical Activities from the University of Laval.
Roland Boivin – Chief Financial Officer
Mr. Boivin has been appointed CFO of Pediapharm on July 1, 2013. Prior to joining Pediapharm, he held several management positions at 3M Canada, including Business Manager ‑ Consumer Division. In that role, he had overall financial responsibility for the Canadian consumer market. His most recent role at 3M was General Manager ‑ Quebec and he became a member of the Company’s Executive Committee. He is a Certified Six Sigma Black Belt. Mr. Boivin has since developed expertise in Finance, Accounting, Corporate Governance and Continuous Disclosure with small and medium size publicly listed companies. From January 2011 to December 2013, Mr. Boivin was the Chief Financial Officer of another company listed on TSX Venture. Mr. Boivin obtained his Bachelor of Commerce from McGill University and his MBA from Queen’s University.
Benoît Hébert, Vice-President, Business Development and Licensing
Benoît Hébert has been the Vice‑President, Business Development and Licensing of Pediapharm since September 2009. Mr. Hébert has more than 20 years of industry experience and has a rare‑blend of scientific expertise and business skills. Focusing on pharmaceutical business transactions since 2000, he worked at Axcan Pharma Inc. from July 2003 to November 2006. Mr. Hébert has lead international licensing transactions, participated actively in product acquisitions, managed international product development alliances and global supplier relationship. Mr. Hébert holds an MBA in Management of Bio‑industries from the Université du Québec à Montréal. Mr. Hébert also received a M.Sc. in Immunology and a Ph.D. in Virology from the Institut Armand‑Frappier. Before returning to Canada in 2000, he was a NSERC postdoctoral fellow in structural biology at Purdue University. He is past‑president and a director of the Canadian Healthcare Licensing Association (CHLA).
Richard Labelle – Vice President, Sales & Marketing
Richard Labelle has been the Vice‑President, Sales and Marketing of Pediapharm since February 2014. Mr. Labelle brings over 26 years of experience in Pharmaceutical and Consumer Health industries. As a Specialty Pharmaceutical Executive, he led various teams in Sales, Marketing and in Business Development. Prior to joining Pediapharm he was Vice-President/General Manager of Sanofi Consumer Health and led during his mandate the creation of the Consumer affiliate in Canada. Over the years he also successfully launched Actonel, a flagship product for Osteoporosis, and re-accelerated growth of one of the largest Cardiovascular franchises. Mr. Labelle obtained his Bachelor of Commerce from the Université du Québec à Montréal and his MBA from McGill-HEC Montreal.